David Wang

Private Equity Investor bei

OrbiMed Advisors Private Equity

Finance

Consumer Services

Health Technology

Profil

David Wang, M.D., Ph.D., is a Partner and Senior Managing Director on the Asia team, focused on Greater China.
Previously, he was a Managing Director at WI Harper Group, responsible for healthcare investments in China.
He also previously served as Head of Business Development at Siemens Medical Solutions, where he directed corporate strategy and new businesses in molecular diagnostics and diagnostic imaging.
Dr. Wang was a co-founder and EVP at First Genetic Trust, a personalized medicine company.
During his tenure at Bristol-Myers Squibb, Dr. Wang was Chairman of The SNP Consortium Management Committee, the first group of its kind formed by pharmaceutical and technology industries to support the development of personalized medicine.
He received his M.D.
from Peking University Medical School, and his doctorate in Developmental Biology from California Institute of Technology.

Aktive Positionen von David Wang

Unternehmen	Position	Beginn
OrbiMed Advisors Private Equity OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies.	Private Equity Investor	01.10.2019

Alle aktiven Positionen von David Wang

Ehemalige bekannte Positionen von David Wang

Unternehmen	Position	Ende
Healthcare Royalty Partners Healthcare Royalty Partners Investment ManagersFinance Functions as an alternative investment manager	Private Equity Investor	02.09.2019
Three Arch Partners Three Arch Partners Investment ManagersFinance Three Arch Partners invests in companies located in the US. The firm targets companies operating primarily in healthcare (medical devices, diagnostics and healthcare services) and occasionally biotechnology. The firm provides financing mainly on early stage companies and seldom on later stage healthcare companies. The firm has an investment range from $0.1 million to $15 million, believes in co-investing with other venture capital funds and remains actively involved in their companies.	Private Equity Investor	02.04.2013
Access Closure, Inc. Access Closure, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes the vascular closure devices in the United States	Direktor/Vorstandsmitglied	01.03.2013

Sehen Sie sich die Erfahrung von David Wang im Detail an

Ausbildung von David Wang

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von David Wang im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	6
Access Closure, Inc. Access Closure, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes the vascular closure devices in the United States	Health Technology
Peking University Peking University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
California Institute of Technology California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Three Arch Partners Three Arch Partners Investment ManagersFinance Three Arch Partners invests in companies located in the US. The firm targets companies operating primarily in healthcare (medical devices, diagnostics and healthcare services) and occasionally biotechnology. The firm provides financing mainly on early stage companies and seldom on later stage healthcare companies. The firm has an investment range from $0.1 million to $15 million, believes in co-investing with other venture capital funds and remains actively involved in their companies.	Finance
OrbiMed Advisors Private Equity OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies.	Finance
Healthcare Royalty Partners Healthcare Royalty Partners Investment ManagersFinance Functions as an alternative investment manager	Finance